Oncozenge AB Cash Flow Reinvestment Rate
Latest as of June 2025:
0.00x
Oncozenge AB cash flow reinvestment rate. Oncozenge AB (ONCOZ) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr263.00K. Explore Oncozenge AB cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Skr0.00
Capex + Investments
Operating Cash Flow
Skr263.00K
SEK
Capital Expenditures
Skr0.00
SEK
Oncozenge AB Cash Flow Reinvestment Rate by Year (None–None)
Oncozenge AB cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Oncozenge AB. For the full cash flow conversion analysis, see ONCOZ cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow